<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">In conclusion, the use or temporary adjustment of antihypertension drugs during infectious disease could be individualized according to volume status, hemodynamic stability, comorbid cardiovascular disease profiles, and antihypertensive drug class. Also, the use of RAS blockade SARS-CoV-2 pandemic before infection should be maintained based on the current scientific knowledge. More researches are needed for the use of antihypertensive drugs before and during severe infection or epidemics.</p>
